Atrás
MoonLake Immunotherapeutics (MLTX) Ganando
Gráfico del Precio de Acciones MLTX
MLTX Ganando
MoonLake Immunotherapeutics
$16.71
-0.94%
$-0.16
Al cierre: Mar 24, 16:00:00 GMT-4
$16.71
0%
$0
Mercado Posterior: Mar 24, 17:21:40 GMT-4
Estadísticas clave
Cierre Anterior
$16.87
Precio de apertura
$16.69
Rango del día
$16.34 - $16.9
Rango de 52 semanas
$5.95 - $62.75
Volumen
490.9K
Volumen promedio
1.9M
Rendimiento de dividendos
--
EPS (TTM)
-3.52
Cap. de mercado
$1.1B
¿Qué es MLTX?
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. The company is headquartered in Zug, Zug and currently employs 130 full-time employees. The company went IPO on 2020-10-20. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The firm develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.